A. Arias-Martínez

Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry

P. Jiménez-Fonseca, L. Visa, A. Carmona-Bayonas, 2022, ESMO open.

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry

M. Alsina, F. Alvarez-Manceñido, V. Arrazubi, 2021, Gastric Cancer.

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

M. Garrido, F. Longo, P. Jiménez-Fonseca, 2020, Gastric Cancer.